Department of Biomedical Sciences, Humanitas University, Milano, Italy; Eye Center, Humanitas Gavazzeni-Castelli, Bergamo, Italy.
IRCCS Policlinico San Martino, Genoa, Italy.
Surv Ophthalmol. 2022 Jul-Aug;67(4):908-931. doi: 10.1016/j.survophthal.2022.01.006. Epub 2022 Jan 31.
The primary repair of full-thickness macular holes (FTMHs) through pars plana vitrectomy with internal limiting membrane peeling and gas tamponade is the current standard of practice and offers a high closure rate of approximately 90%. On the contrary, the surgical management of refractory (or persistent) and recurrent FTMHs is still a challenging and controversial topic in vitreoretinal surgery as multiple options have been suggested, particularly over the last few years, with no consensus regarding any appropriate selection criteria or the best surgical option. Moreover, the presence of various case series / interventional studies presenting comparable outcomes, as well as the absence of studies with a direct comparison of different surgical techniques, may result in confusion. We provide a structured and comprehensive overview of the different surgical options currently available for the secondary repair of refractory and recurrent FTMHs. In addition to an update on epidemiology, diagnosis and description of the surgical steps, we highlight the evidence available to support each of the described surgical techniques, specifically focusing on the presumed mechanisms of hole closure, advantages, and known prognostic factors.
经玻璃体切除术联合内界膜剥除和气体填充治疗全层黄斑裂孔(FTMH)的初次修复是目前的标准治疗方法,其闭合率约为 90%。相反,对于难治性(或持续性)和复发性 FTMH 的手术治疗仍然是玻璃体视网膜手术中的一个具有挑战性和争议性的话题,因为近年来已经提出了多种选择,但是对于任何适当的选择标准或最佳手术选择都没有共识。此外,存在各种病例系列/干预性研究报告了可比的结果,并且缺乏不同手术技术的直接比较研究,这可能导致混淆。我们提供了目前可用于难治性和复发性 FTMH 二次修复的不同手术选择的结构化和全面概述。除了对流行病学、诊断和手术步骤描述的更新外,我们还强调了支持每种描述性手术技术的现有证据,特别关注假定的孔闭合机制、优势和已知的预后因素。